# FDA 483 - Harold D. Hubert, M.D. - July 16, 2021

Source: https://www.keypedia.com/records/483/harold-d-hubert-md/d9da993e-4afa-45fb-b111-b9ad046d7395

> FDA 483 for Harold D. Hubert, M.D. on July 16, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Harold D. Hubert, M.D.
- Inspection Date: 2021-07-16
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Southeastern Clinical Research Institute in Augusta, GA, revealed a significant issue with investigational drug disposition records. The firm failed to contemporaneously record study drug entries into the Master Drug Accountability log, with dispensed dates being entered months to years after the actual dispensing. This indicates a serious lapse in record-keeping practices for clinical trials.

## Related Officers

- [Deborah A. Greco](https://www.keypedia.com/people/deborah-a-greco/38e393b5-55c4-461c-a0b0-4937e0cbec37)

Company: https://www.keypedia.com/companies/harold-d-hubert-md/dee72357-6dc2-43e6-b6da-e63157b3b6f1

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7
